Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer
Yana Debie, Timon Vandamme, Maria E. Goossens, Peter A. van Dam, Marc Peeters
Topics & Concepts
MedicineVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Immune systemCancerAntibody2019-20 coronavirus outbreakImmunologyInternal medicineVirologyDiseaseOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesCOVID-19 Clinical Research Studies